The appointment fills the vacancy left by Nathan Hukill.
AFT Pharmaceuticals (NZX: AFT, ASX: AFP) has today appointed Anita Baldauf as a non-executive director.
The appointment fills the vacancy left by Nathan Hukill who, as president of the company’s former major shareholder CRG, resigned in June 2020 following CRG’s sale of its shareholding in AFT.
Chair David Flacks said: “Anita … brings to the board an outstanding mix of experience in international business development, finance, compliance, personnel development and governance through her 22-year career with Nestlé.
“More recently she has been advising New Zealand startups and new ventures as they navigate the challenges of growth and changing market environments.
“All of this is directly relevant to AFT as we grow and consolidate our presence in Australasia and build our presence,” Flacks said.
Baldauf said she is looking forward to supporting the board, managing director Dr Atkinson and the AFT team to continue its strong growth trajectory.
“Since coming to New Zealand 18 months ago, I have observed AFT and consider it a shining example of Kiwi ingenuity and entrepreneurship,” Baldauf said.
Baldauf, who is a fellow of the Edmund Hillary Fellowship, an organisation aimed at developing solutions to global problems, will stand for re-election to the board at next year’s annual meeting.
This is supplied content and not commissioned or paid for by NBR.
